Product Images Tamsulosin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Tamsulosin Hydrochloride NDC 63187-371 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1

Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2

Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2

This appears to be a figure from a study showing the mean change from baseline in Total AUA Symptom Score (0 to 35) over different durations of treatment in weeks. The study compares the effectiveness of a treatment (2 different doses) and placebo. However, without more context or clearer text, it is difficult to determine specifics of the study or treatment.*

Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3

Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3

The text describes a figure labeled "Figure 2B" which shows the mean change from baseline in total AUA symptom score (ranging from 0 to 35) for different treatments. The treatments listed are "0.08mg LNt", "0.4mg", and "Placebo", with the corresponding score changes shown on the graph. The x-axis indicates the duration of treatment in weeks, while the y-axis shows the mean change values. There are also some numbers in parentheses next to each treatment indicating the sample size for each group at different time points.*

Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4

Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4

The text describes a figure labeled as 3A showing the mean increase in peak urine flow rate in L/sec for Study 1. The figure includes a graph with a line chart placed on the X-axis representing the duration of treatment in weeks and the Y-axis representing the mean change in mL/sec. The treatment options listed include 0.08mg, 2x 0.4mg, and placebo. However, the text does not provide a clear interpretation of the results or the purpose of the study.*

Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5

Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5

This is a graph showing the mean increase in peak urine flow rate (mL/Sec) for Study 2. The x-axis represents the duration of treatment in weeks while the y-axis shows the values of the urine flow rate. The graph shows different treatments denoted by letters and numbers. There is no further information available.*

63187-371-07 - tamsulosin fig6

63187-371-07 - tamsulosin fig6

This is a description of a medication called Tamsulosin HCI 0.4mg, which comes in a bottle of 90 capsules from SNE MASTER. Each capsule contains tamsulosin hydrochloride USP NOC 63187.371.90 and is imprinted with a "D" on its cap and "53" on its body. The product ID is PT037190 and it was made by Aurobindo Pharma Limited in Hyderabad, India. The medication should be stored at 20°C-25°C and kept out of reach of children.*

Chemical Structure - tamsulosin str

Chemical Structure - tamsulosin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.